# BioKier, Inc.: Form D filings

BioKier, Inc., a biotechnology company in Chapel Hill, NC, filed 12 Form D notices with the SEC between 2009 and 2014. The latest, on October 8, 2014, reports $230,000 sold of a $1 million offering to 7 investors.

Find out what BioKier, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20BioKier%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=BioKier%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbiokier-inc-1469459)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20BioKier%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=BioKier%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbiokier-inc-1469459)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 105 GREEN WILLOW COURT, Chapel Hill, NC, 27514
- Phone: (919) 323-6497
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1469459

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 8, 2014 | Amendment | $1,000,000 | $230,000 | $770,000 | 7 | May 23, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945914000002/0001469459-14-000002-index.htm) |
| Aug 4, 2014 | New notice | $1,000,000 | $150,000 | $850,000 | 3 | May 23, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945914000001/0001469459-14-000001-index.htm) |
| Jul 19, 2013 | New notice | $1,710,000 | $645,000 | $1,065,000 | 1 | Jul 12, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945913000003/0001469459-13-000003-index.htm) |
| Jun 7, 2013 | New notice | $400,000 | $40,000 | $360,000 | 1 | May 14, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945913000002/0001469459-13-000002-index.htm) |
| Feb 19, 2013 | Amendment | $400,000 | $340,000 | $60,000 | 17 | Aug 31, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945913000001/0001469459-13-000001-index.htm) |
| Sep 14, 2012 | Amendment | $400,000 | $225,000 | $175,000 | 12 | Aug 31, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945912000004/0001469459-12-000004-index.htm) |
| Apr 18, 2012 | Amendment | $400,000 | $155,000 | $245,000 | 7 | Aug 31, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945912000003/0001469459-12-000003-index.htm) |
| Mar 15, 2012 | Amendment | $400,000 | $105,000 | $295,000 | 6 | Aug 31, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945912000001/0001469459-12-000001-index.htm) |
| Sep 26, 2011 | New notice | $400,000 | $50,000 | $350,000 | 1 | Aug 31, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945911000001/0001469459-11-000001-index.htm) |
| Oct 14, 2009 | Amendment | $250,000 | $249,999 | $1 | 1 | Jul 29, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945909000003/0001469459-09-000003-index.htm) |
| Oct 9, 2009 | Amendment | $250,000 | $199,999 | $50,001 | 1 | Jul 29, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945909000002/0001469459-09-000002-index.htm) |
| Aug 7, 2009 | New notice | $250,000 | $99,999 | $150,001 | 1 | Jul 29, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469459/000146945909000001/0001469459-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| James R Farrelly | Director |  |
| Jerzy R Szewczyk | Executive Officer, Director |  |
| Roger Nolan | Executive Officer, Director |  |

## Other biotechnology companies in North Carolina that filed recently

- [Toggle Bio](https://specstream.ai/data/form-d/company/toggle-bio-2158695) $200,000 · Oct 6, 2026
- [Swift Cardiovascular, Inc.](https://specstream.ai/data/form-d/company/swift-cardiovascular-inc-2117135) $810,000 · Sep 24, 2026
- [Aclarity Genomics, Inc.](https://specstream.ai/data/form-d/company/aclarity-genomics-inc-2153126) $4.6 million · Sep 2, 2026
- [Aer Therapeutics, Inc.](https://specstream.ai/data/form-d/company/aer-therapeutics-inc-1959576) $3 million · Aug 19, 2026

[Every Form D from the week of Oct 6, 2014](https://specstream.ai/data/form-d/week/2014-10-06) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what BioKier, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).